Literature DB >> 25628349

What are the radiologic findings predictive of indolent lung adenocarcinoma?

Takahiro Mimae1, Yoshihiro Miyata1, Yasuhiro Tsutani1, Takeshi Mimura1, Haruhiko Nakayama2, Sakae Okumura3, Masahiro Yoshimura4, Morihito Okada5.   

Abstract

OBJECTIVE: Small pulmonary nodules are often followed up. This study aimed to establish radiographic criteria with which to accurately and reproducibly predict indolent cancers including adenocarcinoma in situ.
METHODS: We examined correlations between pre-operative factors and surgical outcomes, including pathological findings and prognosis among 609 patients with clinical Stage IA lung adenocarcinoma that had been completely resected at multiple institutions. Indolent cancers were defined as tumors without lymphatic, blood vessel, pleural invasion or lymph node involvement (LY0V0PL0N0) regardless of stromal invasion.
RESULTS: Pathological assessments of specimens of 35 of 85 (41%) pure ground glass opacity tumors including 3 (23%) of 13 pure ground glass opacity tumors ≤ 1 cm, revealed partially invasive components. Receiver operating characteristic curves for LY0V0PL0N0 revealed solid tumor size ≤ 6 mm on high-resolution computed tomography or maximum standardized uptake values ≤ 0.6 on 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography as radiographic indolent tumor criteria for predicting indolent tumors. Among 216 (35.5%) of 609 patients who met these criteria, none developed recurrence over a median follow-up of 41.6 months.
CONCLUSIONS: Pure ground glass opacity lesions on high-resolution computed tomography could pathologically include invasive components and would not correspond to adenocarcinoma in situ. Solid tumor size on high-resolution computed tomography and maximum standardized uptake values on positron emission tomography/computed tomography can predict indolent LY0V0PL0N0 lung tumors that can be followed up.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  SUVmax; follow-up; indolent; lung adenocarcinoma; solid tumor

Mesh:

Substances:

Year:  2015        PMID: 25628349     DOI: 10.1093/jjco/hyv005

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  9 in total

1.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

2.  Strategy of intentional limited resection for lung adenocarcinoma in situ.

Authors:  Terumoto Koike; Teruaki Koike; Masaya Nakamura; Yuki Shimizu; Tatsuya Goto; Seijiro Sato; Masanori Tsuchida
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Verification of T descriptor with consolidation size for sub-centimeter non-small cell lung cancer.

Authors:  Masaki Goto; Koji Kawaguchi; Takayuki Fukui; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Shunsuke Mori; Kumiko Hashimoto; Toshinari Ito; Kohei Yokoi
Journal:  Surg Today       Date:  2019-05-22       Impact factor: 2.549

4.  Preoperative Watchful-Waiting Time and Surgical Outcome of Patients with Non-small Cell Lung Cancer Found by Chest Low-Dose CT Screening.

Authors:  Takaomi Hanaoka; Makoto Kurai; Mitsuyo Okada; Satoshi Ishizone; Fumitoshi Karasawa; Akira Iizuka
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

5.  Ground glass opacity: can we correlate radiological and histological features to plan clinical decision making?

Authors:  Duvuru Ram; Holly Egan; Tharumenthiran Ramanathan
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-05-07

6.  Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter.

Authors:  Cheng Chang; Maomei Ruan; Bei Lei; Jian Feng; Wenhui Xie; Hong Yu; Wenlu Zhao; Yaqiong Ge; Shaofeng Duan; Wenjing Teng; Qianfu Wu; Xiaohua Qian; Lihua Wang; Hui Yan; Ciyi Liu; Liu Liu
Journal:  EJNMMI Res       Date:  2022-04-21       Impact factor: 3.434

7.  Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.

Authors:  Takahiro Mimae; Yoshihiro Miyata; Yasuhiro Tsutani; Yoshihisa Shimada; Hiroyuki Ito; Haruhiko Nakayama; Norihiko Ikeda; Morihito Okada
Journal:  JTCVS Open       Date:  2022-05-02

8.  Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema.

Authors:  Takahiro Mimae; Kenji Suzuki; Masahiro Tsuboi; Norihiko Ikeda; Kazuya Takamochi; Keiju Aokage; Yoshihisa Shimada; Yoshihiro Miyata; Morihito Okada
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior.

Authors:  Maria-Fernanda Senosain; Yong Zou; Tatiana Novitskaya; Georgii Vasiukov; Aneri B Balar; Dianna J Rowe; Deon B Doxie; Jonathan M Lehman; Rosana Eisenberg; Fabien Maldonado; Andries Zijlstra; Sergey V Novitskiy; Jonathan M Irish; Pierre P Massion
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.